Rybelsus 7mg Tab - 30's

Rybelsus 7mg Tab - 30's

Category: Drug Info

Specifications
Details

Manufacturer:

- NOVO NORDISK PHARMA (MALAYSIA) SDN. BHD.

Registration Number:

- MAL22056045AZ

Content:

- Semaglutide 7 mg per tablet
(A Can be used as monotherapy if metformin is unsuitable, or in combination with other antidiabetic medications.

  • ingedient:
- Salcaprozate sodium, Povidone K90, Microcrystalline cellulose, Magnesium stearate
Each tablet also contains approximately 23 mg sodium.

 
  • Indications:
    - For the treatment of type 2 diabetes mellitus in adults when diet and exercise alone do not provide adequate glycemic control.
    Can be used as monotherapy if metformin is unsuitable, or in combination with other antidiabetic medications.
     

  • Instructions:

    • Take once daily in the morning, at least 30 minutes before the first food, drink, or other oral medication of the day.

    • Swallow the tablet whole with water; do not chew or crush.

    • Follow your healthcare provider’s dosage schedule and dietary advice.


View more about Rybelsus 7mg Tab - 30's on main site